Raquel Salinas-Gonzalez

Raquel Salinas-Gonzalez

Auto-generated profile, based on publicly available information

Raquel Salinas-Gonzalez

Physical Medicine and Rehabilitation Department, Hospital Clínic de Barcelona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2025 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
MSMaria Queralt Salas
Maria Queralt Salas
RSRaquel Salinas-González
Raquel Salinas-González
LGLaia Guardia
Laia Guardia
MSMaría Teresa Solano
María Teresa Solano
CPCristina Padilla
Cristina Padilla
MRMontserrat Rovira
Montserrat Rovira

7 January 2016 in Spinal Cord Series and Cases
Verified
Journal Article
Open access
RSRs Salinas-González
Rs Salinas-González
LRL Rodríguez-Sánchez
L Rodríguez-Sánchez
RPRa Pelayo-Vergara
Ra Pelayo-Vergara
JBJ Benito-Penalva
J Benito-Penalva
Spinal Cord Series and Cases is an international quarterly subscription based journal, publishing articles and case reports that address all aspects of spinal anatomy, physiology and lesions (injury and disease).

27 March 2026 in Blood Advances
Verified
Journal Article
Open access
RGRaquel Sarahí Salinas Gonzalez
Raquel Sarahí Salinas Gonzalez
LRLAIA GUARDIA ROCA
LAIA GUARDIA ROCA
BSBerta Solé
Berta Solé
CMCristina Moreno
Cristina Moreno
NLNoemi de Llobet
Noemi de Llobet
MSMaria Queralt Salas
Maria Queralt Salas
Frailty has emerged as a key component of allo-HCT candidate assessment and is closely associated with transplant outcomes. Exercise-based prehabilitation may improve transplant candidacy, yet real-world implementation is limited. Our institution implemented a structured Frailty Program (FP) to assess frailty and introduce prehabilitation interventions. This study describes the program’s evolution and evaluates the impact of prehabilitation. Between April 2021 and April 2025, 185 consecutive allo-HCT candidates were included in 3 sequential FP phases. In the first phase (No-Prehab, n = 76), patients underwent frailty assessment only. In the second phase (Pilot-Prehab, n = 59), patients received a home-based, nonsupervised prehabilitation program. In the third phase (Tele-Prehab, n = 50), patients participated in the HCT Pre-App Program, a structured digital telemedicine intervention supervised by rehabilitation physicians. Frailty was assessed at first consultation and HCT admission using the HCT Frailty Scale. Median prehabilitation duration was 6 weeks. Adherence was high across frailty groups (76%-88%), with no adverse events. Prehabilitation improved frailty status: fit patients increased from 22% to 42% in the Pilot-Prehab cohort (P = .009) and from 34% to 56% in the Tele-Prehab cohort (P = .001). Tele-Prehab independently increased the odds of being fit at admission (odds ratio [OR], 3.86; P = .001) and reduced frailty incidence (OR, 0.17; P = .031). One-year OS and NRM were comparable across cohorts (OS, 74.5%, 84.5%, and 78.1%; P = .367) with a trend toward lower NRM among prehabilitated patients (NRM, 14.6%, 5.1%, and 5.6%; P = .075). Frailty is dynamic in allo-HCT candidates, and results support how home-based digital prehabilitation improves fitness before transplantation.

2 March 2026 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
RSRaquel Salinas-Gonzalez
Raquel Salinas-Gonzalez
MLMargarita Calvo López
Margarita Calvo López
CBCarlos Bolaños
Carlos Bolaños
MLMaría Ángeles Castel Lavilla
María Ángeles Castel Lavilla
MGMaría Sanz de la Garza
María Sanz de la Garza
Background: Left ventricular assist devices (LVADs) are a well-established therapy for advanced heart failure (HF) used either as a bridge-to-transplant or destination therapy. While cardiac rehabilitation programmes (CRPs) are guideline-recommended in other HF stages, specific data on their role in LVAD recipients remains limited. We present a case of tailored CRP in a LVAD-supported patient highlighting the importance of understanding the device’s intrinsic limitations to ensure safe and effective exercise prescription. Case summary: A 56-year-old man with cardiovascular risk factors presented with anterior ST-elevation myocardial infarction developing severe left ventricular dysfunction, INTERMACS III, and recurrent ventricular arrhythmias, leading to HeartMate 3 (HM3) LVAD implantation as a bridge-to-transplant. Persistent smoking led to discontinuation of prehabilitation and removal from the transplant waitlist. A destination therapy strategy was considered and referred to the CRP. Baseline and final assessments included a CPET-ESE, clinical-functional evaluation, and PROMs. The rehabilitation physician, as part of the multidisciplinary team, adapted the exercise prescription to manage neuropathic pain due to a suspected spinal cord injury. Doppler-MAP and HM3 LVAD parameters were monitored before and after each session. The patient completed a tailored 12-week CRP with high adherence and no major adverse events. Improvements were observed in submaximal CPET parameters: VO₂ at VT1, OUES and VE/VCO₂ slope, right ventricle contractility, muscular efficiency, and QoL. Persistent smoking remained the main management challenge. Discussion: Tailored CRP with careful haemodynamic monitoring is safe, feasible, and effective in patients with HM3 LVAD. A multidisciplinary approach is essential to optimize functional outcomes and long-term prognosis.